Source - LSE Regulatory
RNS Number : 6498G
Martin Currie Global Portfolio Tst
02 October 2024
 

Martin Currie Global Portfolio Trust plc

Legal Entity Identifier: 549300RKB85NFVSTBM94

 

Half-yearly report - six months to 31 July 2024

 

A copy of the Half-yearly report for the six months to 31 July 2024 has been submitted to the National Storage Mechanism and will shortly be available for inspection.

 

A copy of the Half-yearly report can be downloaded at www.martincurrieglobal.com.

 

FINANCIAL HIGHLIGHTS

 

 

Key data

Six months ended

31 July 2024

Six months ended

31 July 2023

Net asset value per share ('NAV') total return1,2

4.4%

8.9%

MSCI All Country World index (benchmark) total return1

11.5%

5.5%

Share price total return1

5.8%

10.5%

Ongoing charges (as a percentage of shareholders' funds)4

0.64%

0.63%

Revenue return per share5

1.52p

1.56p

Dividend per share

1.80p

1.80p

 

Past performance is not a guide to future returns. All returns are total returns unless otherwise stated.

Source: Martin Currie Investment Management.

 

1Total return is the combined effect of the rise and fall in the share price, net asset value or benchmark together with any dividend paid. See the Half-yearly report for more details on Alternative Performance Measures.

2The net asset value per share total return is calculated using the cum income net asset value with dividends reinvested on the ex-dividend date. This is an Alternative Performance Measure, see the Half-yearly report for more details.

3The benchmark with effect from 1 February 2020 is the MSCI All Country World index.  Prior to this, the benchmark was the FTSE World index to 31 January 2020.  Prior to this, the benchmark was the FTSE All-Share to 31 May 2011.

4Ongoing charges (as a percentage of shareholders' funds) are calculated using average net assets over the period. The ongoing charges figure has been calculated in line with the Association of Investment Companies ('AIC') recommended methodology. This is an Alternative Performance Measure, see the Half-yearly report for more details.

5For details of calculation, refer to note 3.

 

 

INTERIM MANAGEMENT REPORT

CHAIR'S STATEMENT

 

Dear shareholder,

 

Investment Performance

The Company's net asset value total return for the six months under review was +4.4%. This lagged the return of our benchmark index, which was +11.5%. Our investment manager is of course focused on longer-term performance and investment in companies with robust earnings and prospects of superior long-term growth, by understanding fundamental changes and trends in economies and businesses. The resulting portfolio is a focused list of companies and it differs materially from the make up of the benchmark index. As set out in the Manager's review, a small number of holdings in the portfolio were responsible for the underperformance against the benchmark index and the majority of the portfolio continues to perform well at the earnings level.

 

However, equity investments are best made for the long term. This year is the 25th anniversary of our Company in its present form. Over that period the share price is up 6.6 times on a total return basis (as shown by the chart on page 2 of the Half-yearly report), a compound return of 8.3 percent per annum.

 

Income and dividends

Net revenue earnings per share for the six months amounted to 1.52 pence per share. As we have set out in recent reports to shareholders, capital growth is the primary focus of the investment manager and the investment strategy is not constrained by any income target but, recognising the importance of dividends for many shareholders, the Board intends to maintain the recent level of distributions when it is prudent to do so. Dividends have historically been paid quarterly and in recent years the Company has paid three interim dividends of 0.9 pence per share and a fourth interim dividend of 1.5 pence per share for each financial year. The Company paid a first interim dividend for the current financial year of 0.9 pence per share on 26 July 2024 and will pay a second interim dividend of 0.9 pence per share on 25 October 2024, maintaining the same level as the last financial year.

 

Gearing

The Company has an unsecured three-year £10 million sterling revolving loan facility agreement with The Royal Bank of Scotland International Limited. The Board recognises the potential for a modest level of gearing to enhance investment returns over the long term and the full £10m available under the facility is drawn down. Gearing was 4.0% as at 31 July which the Board considers prudent in the current environment.

 

Promoting the Company

The Board and investment manager continue to believe that making investors aware of the attractions of investing in the Company is an essential part of our role and we will continue actively and energetically to market the Company as part of our long-term strategy. Franklin Templeton is very active in promoting the Company, including regular meetings with major shareholders, a wide variety of online marketing designed to encourage investors to go to our interesting and informative website, and regular press coverage of the portfolio manager's distinctive investment style.

 

The Company is recognised as a long-term leader in ESG investing and continues to maintain the highest possible 'Five Globes' from Morningstar. It is also rated in the top 2% of over 8,000 funds in Morningstar's global large cap category for ESG. The Board believes that the Company's distinctive approach to investing is important in stimulating demand for shares in a crowded market and against a background of continuing focus on the environment, and in particular climate change, and on social and governance issues.

 

Demand for investment trusts in general remains lacklustre and we note that a number of investment trusts have announced initiatives to increase their rates of share buybacks in response to wide and persistent discounts. In contrast, we have for some years operated our zero discount policy under which the Company buys back and issues shares with the objective of providing shareholders, in normal market conditions, with:

assurance that the share price is aligned with the prevailing NAV per share; and

liquidity, so that investors can buy or sell as many shares as they wish at a price which is not materially different from the NAV.

 

During the six months under review, the Company bought back 4,827,873 shares which were placed in Treasury and no shares were issued. We continued to be successful in achieving the aims of the zero discount policy, with the share price generally remaining close to NAV. Shares which are bought back are held in Treasury rather than cancelled as they can be reissued from Treasury at lower cost than issuing new shares.

 

Annual General Meeting

Each resolution at this year's AGM was passed by a large majority and I would like to thank shareholders for their continuing support.

 

Outlook

The economic outlook for the world remains difficult to predict. While the effects of Covid-19 are gradually fading into history, conflicts in Ukraine and Gaza along with geopolitical tensions elsewhere in the world continue to be causes for concern. As described in more detail in the Manager's review, central banks continue to tread a fine line in using interest rates to control inflation while not stifling growth. The volatility in share prices for a few days in August of this year clearly illustrated that markets can be highly unpredictable and susceptible to large swings in prices.

 

Your Company invests in companies with resilient earnings growth, exposed to long-term structural growth themes, that have pricing power and solid balance sheets and which should be well placed to produce superior returns for shareholders, looking through the noise of price swings in the short term. I noted in the Annual Report that there will inevitably be challenges along the way and that equity markets will always be prone to volatility in the face of bad news. Our investment manager will continue to focus on a portfolio of high quality, growing companies with the aim of producing long-term performance for the Company's shareholders and we have every confidence that long-term returns will be attractive.

 

Keep in touch

The Company's website at www.martincurrieglobal.com is a comprehensive source of information and includes regular portfolio manager updates and outlook videos, monthly performance factsheets and independent research reports. I recommend that you subscribe for regular email updates that will keep you abreast of the news on your Company. Please contact me if you have any questions regarding your Company by email at: ftcosec@franklintempleton.com.

 

 

 

Christopher Metcalfe

Chair

2 October 2024

 

 

MANAGER'S REVIEW

The first six months of the financial year have been volatile as far as markets are concerned and challenging for the performance of the Company.  The market was up +11.5% during the period, whilst the NAV of the Company was up +4.5% on a total return basis. Whilst we realise that the weak short-term relative performance will be disappointing to our shareholders, we remain confident that the exposures that we have in the Company are enabling us to harness attractive structural growth opportunities across themes that we favour, as we detail further down in this report. Our long-term investment approach permits us to look through the shorter-term market gyrations, and focus our shareholders' capital on what we see as the most promising opportunities within the quality growth segment of the market. We define this as companies with the ability to generate high returns on invested capital, that have solid balance sheets and an attractive growth profile looking into the future.

 

During the six months to 31 July, the strong return of the market continued to be dominated by the Artificial Intelligence ('AI') theme. However, performance of various stocks within this theme has been more disparate than last year. The 'Magnificent 7'1 basket has not produced uniform returns; some stocks continue to perform strongly during the period, with Nvidia (+89%) remaining the standout stock, whilst Tesla (+23%), Alphabet (+22%), Meta (+21%), Apple (+20%) and Amazon (+19%) have also been strong, but to a much lesser extent. Microsoft was the laggard, being only up by +5% during the period (all data total returns: see Glossary in the Half-yearly report).

 

Generally, the market has regarded Big Tech as being the winners of AI, in a broad-brushed manner, which in our view is an overly simplistic conclusion to make, given the different exposures, investment needs, and varying degrees of growth prospects and return prospects that each of the businesses faces. This explains why we have been focused on only two of the 'Magnificent 7' stocks, Nvidia and Microsoft, given our focus on growth and returns assessments, and our valuation discipline. We believe that Nvidia and Microsoft have an attractive growth profile, and high and rising ROICs over our forecast period, and valuations remain supportive for both stocks in our view. These two companies are also best positioned to harness the AI opportunity, and the structural growth that is likely to come from that seismic thematic shift. We detailed the reasons for our preference in a report earlier this year, entitled "The Formidable Two amongst the Magnificent Seven", which our shareholders can access on the Company's website.

 

At the sectoral level, the strongest performing sectors during the period were Technology, up by +17%, Utilities +14%, and Financials +13%, whilst the weakest sectors were Consumer Staples, up only +4.3%, Materials +6.5% and Real Estate +6.5%. Some of these sectors, such as Utilities and Financials in general, remain unattractive to us, given their weak return profiles, low growth potential, and often challenging business dynamics, both in terms of competitive pressures, pricing pressures, and disruption risk.

 

The other focal point for the market during the period has been inflation, and the implications for interest rates. On the inflation front, the picture has remained mixed, with inflation showing an element of ongoing stickiness. This has led the major central banks to delay their intended interest rate cuts during the first half of the year, with the European Central Bank only initiating its first cut in June, followed by one more in September, whilst in the US the Federal Reserve only made its first move in September.  The delay in major central banks moving towards rate cuts is in line with what we had predicted in our outlook for 2024. Now that major central banks have shifted into monetary policy easing, the focus will be on the speed of further rate cuts. The market is now looking for significant cuts in the second half of this year, and over the next 12 months, which could in itself create some short-term risks and increased volatility, depending on what the central banks decide to do. We remain of the view that central banks will be slower in cutting rates than is generally expected, as they understand only too well both the imperative of tackling stubborn inflation properly, and not letting the inflationary fire reignite, given that it is more difficult to extinguish inflation than it is to reignite growth.

 

On the growth front, as we write, the market has gone through a fear of hard landing, as some recent macroeconomic data points have come in weaker, notably in China and in the US, the two largest economies globally. Consumer spending has been generally weak across the US, Europe and China, weighing on sentiment and on economic momentum generally, whilst Industrial Production has also been generally soft. As we look forward, the leading indicators are pointing to weak activity generally, both on the manufacturing and services sides, and across most geographies. We see an ongoing risk of a slowdown in economic growth over the next 12 months, and maintain our probability of recession at c.35-40% - i.e. not our central scenario, but not a negligible risk. We note that some brokers have been increasing their probability of recession in the past months as well.

 

This weakening economic growth has been translating into mixed earnings momentum since the start of the year. Whilst the earnings momentum improved in the first 3-4 months, this was in large part driven by the technology and communications sectors. With the most recent results season, earnings momentum is turning more negative again, with many profit warnings and downgrades, notably in the consumer sectors. Consensus estimates for overall earnings growth for the year 2024 might prove to be too optimistic, sitting at c.+10% at the Global level, +10% at the US level, and +6% in Europe.

 

Against this backdrop of ongoing sticky inflation, weaker economic momentum and weakening corporate earnings, we continue to focus on finding companies with resilient earnings, pricing power, solid balance sheets and exposure to structural growth prospects.

 

The final angle to mention is the political and geopolitical uncertainty across various geographies. The key event this year has been the surprise snap election in France, which led to a hung parliament.

 

This brought particular volatility in European equities, notably in the French market. The UK elections leading to a landslide win by the Labour Party was, in comparison, a rather predictable outcome. Geopolitical tensions have been rising, both in the Ukraine-Russia conflict, and in the Middle East. As we head into the second half of the financial year, the key focus will be the US elections, with a regain of momentum by the Democrats following the change of candidate to Kamala Harris. The polls are still too narrow to take a strong stance on who could emerge as the winning candidate at this stage. This event could fuel some volatility in markets as we approach election day in November, especially given that potential implications for economic growth and corporate profits can be very different, depending on which candidate wins. We will review this topic in a report later this year, which will be available on the Company's website to our readers interested in reading more about this.

 

Below, we review portfolio transactions during the period, and the strongest and weakest stock performers.

 

Stock Contributors

Nvidia - Nvidia continued its strong start to 2024, up +89% during the period, with a series of snippets from the value chain confirming that the semiconductor chain supporting GPU/AI2 chips remained tight with demand exceeding supply. Nvidia reported earnings in the period in which they beat analysts' forecasts and raised future earnings projections. The annual Nvidia GTC conference - an AI conference for developers - showcased Nvidia's new product portfolio with the Grace-Blackwell Superchip which reinforced investors' perception of its strong lead against competitors, with the gap widening in our view.

 

Ferrari - In an otherwise challenging environment, Ferrari was up +17% and continued to demonstrate real strength in order books and to see very strong growth in average selling prices driven by model delivery mix. We believe that this is a function of real pricing power and continued levels of unsatiated demand. We also see continued acceleration in personalisation of products driving better financial outcomes for the group, whilst driving increased engagement with customers.

 

Mettler Toledo - Mettler delivered a solid performance in the period, up +30%, as the company resolved the shipping disruptions which affected the results in the fourth quarter of 2023. This led to returns exceeding the guidance issued in the first quarter of 2024 and a slight upward revision to its full year guidance. Despite maintaining a cautious stance regarding the demand environment, particularly in China which remains a significant challenge, the company's new product launches across the portfolio have been well-received. As a result, there is cautious optimism despite the company not assuming any improvement in the underlying market in the second half of the year.

 

Stock Detractors

Estée Lauder - We continued to see weak performance from Estée Lauder during the period, down -24%, as excess inventory positions continue to reduce, but at a slower pace than expected given the weaker end consumer demand in China in particular.  We are also seeing consumer weakness in other key markets like the US, some of which is market channel related but also largely driven by a weaker outlook due to interest rate increases and inflationary pressures. We continue to believe that Estée Lauder is well positioned in luxury personal care as penetration of key categories increases with access and income growth.

 

Sartorius Stedim - Sartorius reported second quarter results in line with market expectations, although the full year guidance was brought down by 4% on sales, and 9% on earnings, which weighed on the share price near term, with the stock down -27% during the period. Sartorius also held its Capital Markets Day during the period, reiterating unchanged long-term expectations for low-to-mid teens growth in sales, supported by improving trends in biotech funding and clinical trials. The long-term outlook for the company remains intact and the earnings guidance to 2028 was maintained, and our conviction in the name remains strong.

 

Illumina - The focus in the period for Illumina was the disposal of Grail, which occurred sooner than expected. This was taken by the market as a positive step with Illumina's shares up by +36% since the board approval of the spin-off of Grail on 3 June, although the stock was still down -15% over the 6-month period we are reviewing. In addition, Illumina made a small acquisition of Fluent Biosciences, a developer of emerging single-cell technology that eliminates the need for complex instrumentation that would be used in combination with sequencing. This is not material financially but is a positive move strategically. The company also delivered a strong set of results, beating consensus estimates on sales and EPS3 and reiterating the flat expectation for full year growth.

 

Portfolio activity

In the half year period, we initiated new positions in the listed private equity group, Partners Group, the biopharma company Novo Nordisk, and the semiconductor equipment company BE Semiconductors ('BESI'). On the other side we sold out of Nike and Adobe.

 

We see favourable industry dynamics within private asset managers, with a strong growth profile from increasing wealth and high barriers to entry. Partners Group is a high-quality middle market private asset manager that is well placed to benefit from the secular trend we foresee in the private equity space, given the company's robust investment approach, consistent track record and a hard-to-replicate product offering that appeals to both large institutional investors and private wealth customers. Partners Group has been growing its assets under management at 10-15% per year and has a ROIC3 of over 30%.

 

Novo Nordisk is a pure-play organic research & development biopharma company focused on diabetes (Insulin & GLP-1s3), obesity (GLP-1s) and 'Bio-pharma' (mostly haemophilia). Diabetes is a structural growth category which has a stable, low competition market structure in insulin (21% of sales) & diabetes GLP-1's (53% of sales) because of three factors: (i) Manufacturing scale, (ii) Net price discounts and (iii) intellectual property protection (until 2031). Obesity (18% of sales) will, with high probability, be the largest drug category of all time by 2030. It is expected to provide substantial growth but the market structure will be less attractive due to limited patent protection resulting in short product cycles, and threats from new entrants. Novo Nordisk is expected to deliver sales growth ahead of the peer group, with industry leading margins.

 

BESI, a leader in semiconductor packaging technology, is a beneficiary of trends such as the ongoing need for miniaturisation despite the physical challenges of doing so. Next generation semiconductor designs are gaining traction with Intel, TSMC and Samsung, who are all investing materially more into semiconductor packaging after decades of neglect. The apex of this opportunity centres on die-to-wafer hybrid bonding - where we believe that BESI has a multiyear head-start, and is ahead of competition. We expect hybrid bonding to progress from 0% of sales to over 50% of the BESI business in the long term. Key applications centre on computing, high bandwidth memory, and smartphone applications. We also expect that the hybrid bonding business will be significantly accretive to earnings. Following weak results in the second quarter of 2024 due to shorter term macro issues, we believe the hybrid bonding opportunity has become relatively de-risked for a range of applications, and believe therefore it is the right time to enter a position in the stock.

 

We exited our position in Adobe due to uncertainty over Adobe's long-term competitive advantage due to the disruptive threat of generative AI. Adobe's generative AI product (Firefly) deserves credit, however competitors are developing advanced solutions that may encroach on Adobe's designer space going forward. Overall, we believe that Adobe's AI product portfolio is nascent and still some way away from meaningful monetisation.

 

Nike's poor recent results led to a significant downgrade of projections for the 2025 financial year. Projections had already been lowered in the third quarter of 2023, in large part due to internal issues in our view. The downgrade is due to below par innovation and overextension of key franchises (e.g. AF1, Dunks, Pegasus, AJ1, Air) which need revitalization. CEO Jon Donohue's restructuring by divisions rather than sport categories has failed and been reversed. The push into higher-margin areas has exposed Nike to new competition in the wholesale channel and strained partnerships. Our previous conviction in Nike shifting profitability higher while growing market share has diminished and our updated target price had limited upside, leading to the decision to sell the holding.

 

Thematic opportunities still abound within our three mega-trends

As we look into the remainder of 2024 and beyond, through our 5-10 years' time horizon, we continue to see many attractive thematic opportunities for long term investors to harness. We continue to focus on eight mid-term thematic opportunities, which sit within our three mega-trends of (1) demographic changes, (2) future of technology and (3) resource scarcity.

 

These eight mid-term themes are bundled into three broad areas: energy transition, ageing population and artificial intelligence, where we see seismic shifts, and a long and supportive investment cycle in each of them. We have detailed our view on these three seismic thematic shifts in a report earlier this year, also available on the Company's website.  See the chart of thematic opportunities in the Half-yearly report.

 

At the same time as focusing on the above thematic opportunities, we also continue to favour companies with resilient earnings, pricing power, solid balance sheets and exposure to structural growth opportunities, given the challenging growth dynamics at the market level in general in our view.

 

I would like to finish by thanking all our shareholders for their continued support and confidence, whilst we go through a period of volatility and challenging short-term performance. I would like to also reiterate our confidence in our ability to gain exposure to the most attractive quality growth stocks globally, exposed to long-term structural thematic opportunities, as a result of our in-depth fundamental research approach, and structured investment process. As always, I am looking forward to the ongoing interactions with our shareholders.

 

Zehrid Osmani

Lead Senior Portfolio Manager, Martin Currie Global Portfolio Trust plc

2 October 2024

 

1The so-called 'Magnificent 7' stocks which are believed to be key beneficiaries of the growing adoption of AI are Apple, Microsoft, Alphabet, Amazon, Nvidia, Meta and Tesla.

2GPU/AI's are specialised graphics processing units designed to handle the intensive computation required for artificial intelligence and machine learning tasks.

3See Glossary in Half-yearly report.

4GLP-1s are medications that help lower blood sugar levels and promote weight loss.

 

 

PORTFOLIO SUMMARY

 

By sector


 

31 July 2024

Company %

31 July 2024

MSCI All Country World index %

 

31 January 2024

Company %

31 January 2024 MSCI All Country World index %

Healthcare

29.2

11.1

22.8

11.4

Information Technology

28.3

24.9

30.8

23.5

Consumer Discretionary

9.9

10.3

12.0

10.8

Industrials

9.7

10.6

12.2

10.6

Financials

8.7

16.1

7.2

16.0

Materials

7.1

4.0

7.7

4.2

Consumer Staples

7.1

6.3

7.3

6.7

Communication Services

-

7.6

-

7.5

Energy

-

4.4

-

4.5

Utilities

-

2.6

-

2.5

Real Estate


2.1

-

2.3


100.0

100.0

100.0

100.0

 

 

By asset class


31 July 2024 %

31 January 2024 %

Equities

103.2

103.1

Cash

0.8

0.8

Less borrowings

(4.0)

(3.9)


100.0

100.0

 

Portfolio distribution by region


 

31 July 2024

Company %

31 July 2024

MSCI All Country World index %

 

31 January 2024

Company %

31 January 2024 MSCI All Country World index %

Developed Europe

50.4

14.8

44.4

15.6

North America

46.6

67.2

52.2

66.0

Developed Asia Pacific ex Japan

3.0

2.4

3.4

2.6

Global Emerging Markets

-

10.1

-

10.0

Japan

-

5.3

-

5.6

Middle East

-

0.2

-

0.2


100.0

100.0

100.0

100.0

 

Largest 10 holdings






31 July 2024

31 July 2024

31 January 2024

31 January 2024


Market value

% of total

Market value

% of total


£000

portfolio

£000

portfolio

Nvidia

21,332

8.3

24,357

9.2

Microsoft

15,438

6.0

17,136

6.5

Linde

13,249

5.2

13,818

5.2

ASML Holding

12,853

5.0

14,074

5.3

Ferrari

11,877

4.6

11,792

4.5

Moncler

10,089

3.9

10,341

3.9

Atlas Copco

10,064

3.9

10,576

4.0

Mastercard

10,022

3.9

11,341

4.3

Novo Nordisk

9,545

3.7

-

-

L'Oreal

9,493

3.7

10,212

3.9

 

GOVERNANCE

 

Risk and mitigation

The principal long-term risks facing the Company are unchanged since the date of the Annual Report for the year to 31 January 2024, as set out on pages 32 and 33 of that report.

 

The Company's business model is longstanding and resilient to most of the short-term operational uncertainties that it faces.  The Board believes these are effectively mitigated by the internal controls established by the Board and by the AIFM1 and their combined oversight of the investment manager.  The Company's principal risks and uncertainties are therefore largely long-term and driven by the inherent uncertainties of investing in global equity markets. The Board's process seeks to mitigate known risks and to identify new risks as they emerge.  The Board's planned mitigation measures are described in the most recent Annual Report. However, it is recognised that the

likelihood and timing of crystallisation of some risks cannot be predicted in advance and the Board then relies on professional management, effective systems and communication to mitigate these risks as and when they arise.

 

The Board identified the following principal risks to the Company in the Annual Report:

•              Sustained investment underperformance

•              Material decline in market capitalisation of the Company

•              Loss of s1158-9 tax status

 

Following the ongoing assessment of the principal and emerging risks facing the Company, and its current position, the Board is confident that the Company will be able to continue in operation and meet its liabilities as they fall due. The Board believes that the processes of internal control that the Company has adopted and oversight by the AIFM continue to be effective.

 

Statement of Directors' responsibilities

In accordance with Chapter 4 of the Disclosure and Transparency Rules and to the best of their knowledge, each director of the Company confirms that the financial statements have been prepared in accordance with the United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law) and with the Statement of Recommended Practice 'Financial Statements of Investment Trust Companies and Venture Capital Trusts' issued by the AIC in July 2022.

 

The directors are satisfied that the financial statements give a true and fair view of the assets, liabilities, financial position and profit of the Company. Furthermore, each director certifies that the interim management report includes an indication of important events that have occurred during the first six months of the financial year and their impact on the financial statements together with a description of the principal risks and uncertainties that the Company faces. In addition, each director of the Company confirms that, with the exception of management and secretarial fees, directors' fees and directors' shareholdings, there have been no related party transactions during the first six months of the financial year.

 

Going concern status

The Company's business activities, together with the factors likely to affect its future development, performance and position, are set out in the Chair's statement and Manager's review.

 

The financial position of the Company as at 31 July 2024 is shown on the unaudited condensed statement of financial position. The unaudited statement of cash flow of the Company is set out below.

 

In accordance with the 2019 AIC Code of Corporate Governance and the 2018 UK Corporate Governance Code, the directors have undertaken a rigorous review of the Company's ability to continue as a going concern.

 

The Company's assets consist of a diverse portfolio of listed equity shares which, in most circumstances, are realisable within a very short timescale. The directors are mindful of the principal and emerging risks disclosed above. 

 

They have reviewed forecasts for the current and following financial year, including liabilities arising from the loan facility, and believe that the Company has adequate financial resources to continue its operational existence for the foreseeable future and for at least one year from the date of signing these financial statements. Accordingly, the directors continue to adopt the going concern basis in preparing these financial statements.

 

Christopher Metcalfe
Chair
2 October 2024

 

1See Glossary in the Half-yearly report

 

 

FINANCIAL REVIEW

 

UNAUDITED CONDENSED STATEMENT OF COMPREHENSIVE INCOME

 

 



(Unaudited) Six months ended 31 July 2024

(Unaudited) Six months ended 31 July 2023


 

Revenue

Capital

Total

Revenue

Capital

Total


Note

£000

£000

£000

£000

£000

£000

Net gains on investments

 

-

11,182

11,182

-

21,115

21,115

Net currency (losses)/gains

 

-

(17)

(17)

-

13

13

Revenue                                

 

1,731

-

1,731

1,772

-

1,772

Investment management fee

 

(119)

(474)

(593)

(117)

(466)

(583)

Other expenses

 

(303)

-

(303)

(237)

-

(237)

Net return on ordinary activities before finance costs and taxation

 

 

1,309

 

10,691

 

12,000

 

1,418

 

20,662

 

22,080

Finance costs

 

(69)

(274)

(343)

(35)

(141)

(176)

Net return on ordinary activities before taxation

 

 

1,240

 

10,417

 

11,657

 

1,383

 

20,521

 

21,904

Taxation on ordinary activities

 

(196)

-

(196)

(217)

-

(217)

Net return attributable to shareholders

 

 

1,044

 

10,417

 

11,461

 

1,166

 

20,521

 

21,687

Net return per Ordinary share 

 

3

1.52p

15.17p

16.69p

1.56p

27.38p

28.94p

 

The total columns of this statement are the profit and loss accounts of the Company.

The revenue and capital items are presented in accordance with the Association of Investment companies ('AIC') Statement of Recommended Practice 2022.

All revenue and capital items in the above statement derive from continuing operations.

No operations were acquired or discontinued in the six months.

The notes below form part of these financial statements.

There is no other comprehensive income and therefore the return attributable to shareholders is also the total comprehensive income for the period.   

 

 

UNAUDITED CONDENSED STATEMENT OF FINANCIAL POSITION

 



(Unaudited) As at 31 July 2024

(Audited) As at 31 January 2024


Note

£000

£000

£000

£000

Non-current assets






Investments at fair value through profit or loss



 

256,571


 

264,787

Current assets






Trade receivables


392


1,029


Cash and cash equivalents


2,106


1,922





2,498


2,951

Current liabilities






Trade payables


(598)


(961)


Bank loan


(10,000)


(10,000)





(10,598)


(10,961)

Total net assets



248,471


256,777







Equity






Called up Ordinary share capital



4,934


4,934

Share premium account



11,823


11,823

Capital redemption reserve



11,083


11,083

Capital reserve, of which:

6


219,563


228,307

  Realised capital reserve (distributable)


163,024


156,688


  Unrealised gains on investments (undistributable)


56,539


71,619


Revenue reserve



1,068


630

Total shareholders' funds



248,471


256,777

Net asset value per Ordinary share



374.2p


360.5p

The notes below form part of these financial statements. 

Martin Currie Global Portfolio Trust plc is registered in Scotland, company number SC192761.

The financial statements were approved by the Board of directors on 2 October 2024 and signed on its behalf by

 

Christopher Metcalfe

Chair

2 October 2024

 

 

UNAUDITED STATEMENT OF CHANGES IN EQUITY

 


Called up

Share

Capital




Ordinary

premium

redemption

Capital

Revenue


(Unaudited)

share capital

account

reserve

reserve

reserve

Total

Six months ended 31 July 2024

£000

£000

£000

£000

£000

£000

As at 31 January 2024

4,934

11,823

11,083

228,307

630

256,777

Net return attributable to shareholders

-

-

-

10,417

1,044

11,461

Ordinary shares bought back during the period

-

-

-

(18,120)

-

(18,120)

Dividends paid

-

-

-

(1,041)

(606)

(1,647)

As at 31 July 2024

4,934

11,823

11,083

219,563

1,068

248,471

 

 


Called up

Share

Capital




Ordinary

premium

redemption

Capital

Revenue


(Unaudited) 

share capital

account

reserve

reserve

reserve

Total

Six months ended 31 July 2023

£000

£000

£000

£000

£000

£000

As at 31 January 2023

4,934

11,424

11,083

221,463

864

249,768

Net return attributable to shareholders

-

-

-

20,521

1,166

21,687

Ordinary shares issued during the period

-

399

-

1,940

-

2,339

Ordinary shares bought back during the period

-

-

-

(6,742)

-

(6,742)

Dividends paid

-

-

-

(1,118)

(675)

(1,793)

As at 31 July 2023

4,934

11,823

11,083

236,064

1,355

265,259

 

 

 

 


Called up

Share

Capital




Ordinary

premium

redemption

Capital

Revenue


(Audited)

share capital

account

reserve

reserve

reserve

Total

Year ended 31 January 2024

£000

£000

£000

£000

£000

£000

As at 31 January 2023

4,934

11,424

11,083

221,463

864

249,768

Net return attributable to shareholders

-

-

-

24,327

1,750

26,077

Ordinary shares issued

-

399

-

1,940

-

2,339

Ordinary shares bought back during the year

-

-

-

(18,305)

-

(18,305)

Dividends paid

-

-

-

(1,118)

(1,984)

(3,102)

As at 31 January 2024

4,934

11,823

11,083

228,307

630

256,777

 

The notes below form part of these financial statements. 

 

UNAUDITED STATEMENT OF CASH FLOW

 


(Unaudited)

Six months ended

31 July 2024

(Unaudited)

Six months ended

31 July 2023


£000

£000

£000

£000

Cash flows from operating activities


 

 



Net return on ordinary activities before taxation

11,657


21,904


 

Adjustments for:





Gains on investments

(11,182)


(21,115)


Finance costs

343


176


Dividend income recognised

(1,705)


(1,757)


Interest income recognised

(26)


(15)


Decrease/(increase) in receivables

48


(15)


Increase/(decrease) in payables

29


(59)


Overseas withholding tax suffered

(196)


(217)


Net cash outflows from operations

(1,032)


(1,098)







Dividends received

1,602


1,694


Interest received

26


15


Overseas withholding tax recovered

37


12


Net cash flows from operating activities


633


623






Cash flows from investing activities





Purchases of investments

(48,684)


(49,045)


Sales of investments

68,737


56,033


Net cash flows from investing activities


20,053


6,988






Cash flows from financing activities





Repurchase of Ordinary share capital

(18,515)


(7,267)


Shares issued for cash

-


2,339


Equity dividends paid

(1,647)


(1,793)


Interest and fees paid on bank loan

(340)


(176)


Net cash flows from financing activities


(20,502)


(6,897)

Net increase in cash and cash equivalents


184


714

Cash and cash equivalents at the start of the period


1,922


1,256

Cash and cash equivalents at the end of the period


2,306


1,970

 

The notes below form part of these financial statements. 

 

Analysis of debt


(Audited)

As at 31 January 2024

£000

 

Cash flows

£000

(Unaudited)

As at 31 July 2024

£000

Cash at bank

1,922

184

2,106

Bank loan

(10,000)

-

(10,000)

Net debt

(8,078)

184

(7,894)

 

 


(Audited)

As at 31 January 2023

£000

 

Cash flows

£000

(Unaudited)

As at 31 July 2023

£000

Cash at bank

1,256

714

1,970

Bank loan

(30,000)

-

(30,000)

Net debt

(28,744)

714

(28,030)

 

 

NOTES TO THE CONDENSED FINANCIAL STATEMENTS

 

Note 1: Financial statements

The financial information contained in this half-yearly report does not constitute statutory accounts as defined in s434 (3) of the Companies Act 2006. The financial information for the six months ended 31 July 2023 has not been audited or reviewed by the Company's independent auditors.

 

The information for the year ended 31 January 2024 has been extracted from the latest published audited financial statements which have been filed with the Registrar of Companies. The report of the auditors on those accounts contained no qualification or statement under s498 (2), (3) or (4) of the Companies Act 2006.

 

Note 2: Accounting policies

For the period ended 31 July 2024 (and the year ended 31 January 2024), the Company is applying the Financial Reporting Standard applicable in the UK and Republic of Ireland ('FRS 102'), which forms part of the revised Generally Accepted Accounting Practice ('UK GAAP') issued by the Financial Reporting Council ('FRC'). 

 

These condensed financial statements have been prepared on a going concern basis in accordance with the Disclosure and Transparency Rules of the Financial Conduct Authority, FRS 102 issued by the FRC in September 2015, FRS 104 Interim Financial Reporting issued by the FRC in March 2015 and the revised Statement of Recommended Practice "Financial Statements of Investment Trust Companies and Venture Capital Trusts" ('SORP') issued by the AIC in July 2022.

 

The accounting policies applied for the condensed set of financial statements are set out in the Company's Annual Report for the year ended 31 January 2024.

 

Note 3: Net returns per Ordinary share

 

 

(Unaudited)

Six months ended 31 July 2024

£000

(Unaudited)

Six months ended 31 July 2023

£000

Revenue return

1,044

1,166

Capital return

10,417

20,521

Total return

11,461

21,687




Weighted average number of shares in issue during the period

68,678,926

74,938,623

Revenue return per share

1.52p

1.56p

Capital return per share

15.17p

27.38p

Total return per share

16.69p

28.94p

 

Note 4: Dividends

 

 

(Unaudited)

Six months ended 31 July 2024

£000

(Unaudited)

Six months ended 31 July 2023

£000

Year ended 31 January 2023 - fourth interim dividend of 1.50p (2023: 1.50p)

1,041

1,118

Year ended 31 January 2025 - first interim dividend of 0.90p (2024: 0.90p)

606

675


1,647

1,793

 

The fourth interim dividend for the years ended 31 January 2024 and 31 January 2023 have been allocated to the realised capital reserve.

The first interim dividend for the years ended 31 January 2025 and 31 January 2024 have been allocated to the revenue reserve.

 

Note 5: Ordinary shares of 5p

 

 

(Unaudited)

Six months to 31 July 2024

(Unaudited)

Six months to 31 July 2023

 

Number of shares

£000

Number of shares

£000

Ordinary shares of 5p

 

 



Ordinary shares in issue at the beginning of the period

 

71,228,807

 

3,560

 

76,105,554

 

3,804

Ordinary shares issued from Treasury during the period

 

-

 

-

 

675,000

 

34

Ordinary shares bought back to Treasury during the period

 

(4,827,873)

 

(241)

 

(2,025,924)

 

(101)

Ordinary shares in issue at end of the period

66,400,934

3,319

74,754,630

3,737

 

 

 

(Unaudited)

Six months ended 31 July 2024

(Unaudited)

Six months ended 31 July 2023

 

Number of shares

£000

Number of shares

£000

Treasury shares (Ordinary shares of 5p)

 

 



Treasury shares in issue at the beginning of the period

 

27,447,100

 

1,374

 

22,570,353

 

1,130

Ordinary shares issued from Treasury during the period

 

-

 

-

 

(675,000)

 

(34)

Ordinary shares bought back to Treasury during the period

 

4,827,873

 

241

 

2,025,924

 

101

Treasury shares in issue at end of the period

32,274,973

1,615

23,921,277

1,197

Total Ordinary shares in issue and in Treasury at the period end

 

98,675,907

 

4,934

 

98,675,907

 

4,934

 

Note 6: Capital reserve

 

Realised capital reserve

£000

Unrealised gains on investments

£000

Total capital reserve

£000

As at 31 January 2024

156,688

71,619

228,307

Net gains on realisation of investments at fair value

26,262

-

26,262

Movement in fair value of investments

-

(15,080)

(15,080)

Realised currency losses during the period

(17)

-

(17)

Cost of shares bought back into Treasury

(18,120)

-

(18,120)

Capital expenses

(748)

-

(748)

Dividends paid

(1,041)

-

(1,041)

As at 31 July 2024

163,024

56,539

219,563

 

 

Realised capital reserve

£000

Unrealised gains on investments

£000

Total capital reserve

£000

As at 31 January 2023

154,191

67,292

221,463

Net gains on realisation of investments at fair value

21,284

-

21,284

Movement in fair value of investments

-

4,347

4,347

Proceeds from the issue of shares from Treasury

1,940

-

1,940

Cost of shares bought back into Treasury

(18,305)

-

(18,305)

Capital expenses

(1,304)

-

(1,304)

Dividends paid

(1,118)

-

(1,118)

As at 31 January 2024

156,688

71,619

228,307

 

Note 7: Fair value hierarchy

Under FRS 102, the Company is required to classify fair value measurements using a fair value hierarchy that reflects the significance of the inputs used in making the measurements. The fair value hierarchy has the following levels:

- Level 1: quoted prices (unadjusted) in active markets for identical assets or liabilities;

- Level 2: other significant observable inputs (including quoted prices for similar investments, interest rates, prepayments, credit risk, etc); and

- Level 3: significant unobservable input (including the Company's own assumptions in determining the fair value of investments).

The financial assets measured at fair value through profit and loss are grouped into the fair value hierarchy as follows:

 

 

 

(Unaudited)

Six months ended 31 July 2024

£000

(Audited)

Year ended 31 January 2024

£000

(Unaudited)

Six months ended 31 July 2023

£000

Level 1

256,571

264,787

293,171

Net fair value

256,571

264,787

293,171

 

Note 8: Post balance sheet events

Between 1 August and 27 September 2024, the Company bought back into Treasury 1,147,710 ordinary shares at an average price of 361.9p per share.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR GIBDGSSGDGSD
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account. AJ Bell logo

Related Charts

Martin Currie Global Portfolio Trust PLC (MNP)

-6.40p (-1.72%)
delayed 11:30AM